Yinhuai Wang

15PUBLICATIONS
32CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Obstetrics and gynaecologyMolecular targetsMedical roboticsMedical biochemistry - inorganic elements and compounds
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Aug 29, 2026
DHCR24+ tumor epithelial cells drive cisplatin resistance in bladder cancer by enhancing cholesterol metabolism to activate lipid raft-associated MAPK signaling.

|Aug 04, 2026
Male reproductive surgeries and long-term kidney outcomes: a Mendelian randomization and meta-analysis of UK Biobank and FinnGen.

|Jun 11, 2024
CDK4/6 Alters TBK1 Phosphorylation to Inhibit the STING Signaling Pathway in Prostate Cancer.

Wei Li, Feng Guo, Ruijiang Zeng

|Apr 03, 2024
PRMT4 interacts with NCOA4 to inhibit ferritinophagy in cisplatin-induced acute kidney injury.

Lizhi Zhou, Zebin Deng, Yilong Wang

|Feb 27, 2023
The progress of dorsal vascular complex control strategy in radical prostatectomy.

Yinhuai Wang, Xu Cheng, Qi Xiong

|Jan 08, 2023
Myo-Inositol Supplementation Alleviates Cisplatin-Induced Acute Kidney Injury via Inhibition of Ferroptosis.

Huiyue Qi, Fei Deng, Yinghuai Wang

Pageof 3

Frequent Collaborators

3 joint publications

Hao Zhang

2 joint publications

Fei Deng

2 joint publications

Lizhi Zhou

2 joint publications

Zebin Deng